Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Staphylococcus aureus (oxacillin-susceptible) |
1 |
2 |
? - ? |
Cefpodoxime |
403 |
Staphylococcus aureus (oxacillin-susceptible) |
1 |
2 |
? - ? |
Ceftriaxone (Rocephin) |
403 |
Staphylococcus aureus (oxacillin-susceptible) |
>1 |
>4 |
≤0.5 - >4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
462 |
Staphylococcus aureus (oxacillin-susceptible) |
1 |
4 |
≤1 - >4 |
Gentamicin (Gentamycin, Garamycin) |
462 |
Staphylococcus aureus (oxacillin-susceptible) |
2 |
2 |
0.5 - 2 |
Ceftriaxone (Rocephin) |
267 |
Staphylococcus aureus (oxacillin-susceptible) |
2 |
2 |
0.5 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
265 |
Staphylococcus aureus (oxacillin-susceptible) |
≤2 |
≤2 |
≤2 - >8 |
Gentamicin (Gentamycin, Garamycin) |
265 |
Staphylococcus aureus (oxacillin-susceptible) |
≤2 |
≤2 |
≤2 - ? |
Vancomycin (Vancocyn, Lyphocin) |
462 |
Staphylococcus aureus (oxacillin-susceptible) |
2 |
2 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
39 |
Staphylococcus aureus (oxacillin-susceptible) |
2 |
4 |
≤0.12 - 8 |
Cefepime (Maxipime) |
412 |
Staphylococcus aureus (oxacillin-susceptible) |
2 |
4 |
1 - 4 |
Ceftriaxone (Rocephin) |
462 |
Staphylococcus aureus (oxacillin-susceptible) |
>2 |
>8 |
≤0.06 - >8 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
462 |
Staphylococcus aureus (oxacillin-susceptible) |
>2 |
>8 |
1 - >8 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
496 |
Staphylococcus aureus (oxacillin-susceptible) |
4 |
4 |
≤0.25 - 16 |
Ceftriaxone (Rocephin) |
412 |
Staphylococcus aureus (oxacillin-susceptible) |
>4 |
>4 |
2 - >4 |
Cefixime (Suprax) |
267 |
Staphylococcus aureus (oxacillin-susceptible) |
≤4 |
≤4 |
? - ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
39 |
Staphylococcus aureus (oxacillin-susceptible) |
4 |
6 |
? - ? |
Cefepime (Maxipime) |
126 |
Staphylococcus aureus (oxacillin-susceptible) |
>4 |
>8 |
0.12 - >8 |
Ampicillin (Omnipen) |
462 |
Staphylococcus aureus (oxacillin-susceptible) |
6 |
24 |
? - ? |
Ceftriaxone (Rocephin) |
126 |
Staphylococcus aureus (oxacillin-susceptible) |
8 |
8 |
? - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
403 |
Staphylococcus aureus (oxacillin-susceptible) |
8 |
16 |
≤0.12 - >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
412 |
Staphylococcus aureus (oxacillin-susceptible) |
12 |
16 |
? - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
Staphylococcus aureus (oxacillin-susceptible) |
12 |
16 |
? - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
Staphylococcus aureus (oxacillin-susceptible) |
- |
4 |
1 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
726 |
Staphylococcus aureus (oxacillin-susceptible) |
- |
8 |
8 - ? |
Chloramphenicol (Chloromycetin) |
39 |
Staphylococcus aureus (Oxford) |
- |
- |
0.125 - ? |
Mupirocin (Bactroban) |
101 |
Staphylococcus aureus (Oxford) |
- |
- |
27.5 - ? |
Garlic (Essential oil) (Allicin) |
262 |
Staphylococcus aureus (pansusceptible) |
0.008 |
0.015 |
0.004 - 0.125 |
API-1252 |
169 |